From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past

From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past

Although melanoma remains the deadliest skin cancer, the current treatment has not resulted in the desired outcomes. Unlike chemotherapy, immunotherapy has provided more tolerable approaches and revolutionized cancer therapy. Although dendritic cell-based vaccines have minor side effects, the undesi...

Full description

Bibliographic Details
Main Authors: Mahdi Abdoli Shadbad, Khalil Hajiasgharzadeh, Afshin Derakhshani, Nicola Silvestris, Amir Baghbanzadeh, Vito Racanelli, Behzad Baradaran
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Immunology
Subjects:
dendritic cells
immunotherapy
melanoma development
immune checkpoints
IDO
RNA-modified dendritic cell vaccines
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.623639/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.623639/full

Similar Items